Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN.DL)

CAPS Rating: No stars

A biopharmaceutical company committed to improving the lives of people with diabetes, obesity and other diseases through the discovery, development and commercialization of innovative medicines.

Recs

0
Player Avatar phatchips767 (< 20) Submitted: 6/27/2012 8:08:28 PM : Outperform Start Price: $27.92 AMLN.DL Score: +4.76

portofeille likeeded it.

Featured Broker Partners


Advertisement